Services
Research and Clinical Development
Regulatory
Clinical
Biometrics
CMC
Consulting
Management Consulting
Market Access
Patient Engagement
Transaction Advisory
Lifecycle Optimization
Lifecycle Optimization
Real-World Solutions
Real-World Solutions
Technology
Health Storylines
A digital platform that puts patients at the center and intersection of human networks, technology, and science
b.research
A single, unified SaaS solution for all EU Phase 4, Real-World Evidence, and Post-Approval studies
RedCrow
An equity crowdfunding and crowdsourcing platform for healthcare innovation
About
Our team
Our team collaborates to fully understand every aspect of each client’s organization from concept ideation to commercial realization, from innovation to implementation
Community involvement
We work with our local and global communities to create positive change through education, service, and sustainable business practices
800+
employees
90+%
has a PhD and/or Masters
15
languages spoken
30
nationalities
Careers
Job openings
Explore our job openings and find the one that is right for you
Why work at Alira Health?
Alira Health is dedicated to providing market-leading professional development, education, travel, and work-life benefits to all team members
Join our team
Join our global team dedicated to innovation and initiative, where physical walls and different time zones don’t limit, but encourage, collaboration
Resources
News
Read all the latest from us
Blog
Insights on healthcare innovation and more
Events
Check out our upcoming events
Publications
Discover our latest industry infographics, articles, white papers, and more
Multimedia
Visit our videos, podcasts, webinars, and more.
Latest in the hub
A Tutorial on Modern Bayesian Methods in Clinical Trials
Published: May, 2023
Specific Requirements for Integrated Summaries of Efficacy and Safety in FDA Submissions
Published: May, 2023
Webinar on Advancing Patient Engagement in the Medical Device / MedTech Industry
Published: May, 2023
Services
Overview
Research and Clinical Development
Regulatory Clinical Biometrics CMC
Consulting
Management Consulting Market Access Patient Engagement Transaction Advisory Lifecycle Optimization
Real-World Solutions
Real-World Solutions
Technology
Overview Health Storylines b.research RedCrow
About
Overview Our team Community involvement
Careers
Overview Job openings Why work at Alira Health? Join our team
Resources
Overview News Blog Events Publications Multimedia
Home > Education Hub > Pre-Commercial Value Assessment of a Nuclear Medicine Pair to Diagnose and Treat Neuroendocrine Tumors (NET)

Pre-Commercial Value Assessment of a Nuclear Medicine Pair to Diagnose and Treat Neuroendocrine Tumors (NET)

Publications
Category:
Pharma
Published on:
August 1, 2020
Written by:
Piergiulio Lauriano

When our client, a leading radiopharmaceutical company, needed support to understand the commercial opportunity represented by a Phase III radiopharmaceutical and its diagnostic radiotracer companion, Alira Health stepped in to run a comprehensive analysis.

Read on to learn how our team analyzed the market, assessed value assets, and helped our client move forward with confidence.

For more information, please contact Piergiulio Lauriano.

For more information about Alira Health’s Management Consulting services

Click here

Related news

Publications May 25, 2023
The EU Pharmaceutical Package: Introduction to Changes
Alira Health’s Regulatory experts explore how the proposed package will disrupt the European regulatory landscape and what it means for companies.
EU Pharma Regulatory
Events May 16, 2023
PSI 2023 Conference
We're excited to talk orphan drugs and rare diseases at the World Orphan Drug Congress in Washington, D.C.
Orphan Drug Pharma Rare Disease UK
Events May 15, 2023
World Orphan Drug Congress USA
We're excited to talk orphan drugs and rare diseases at the World Orphan Drug Congress in Washington, D.C.
Orphan Drug Pharma Rare Disease
Events May 15, 2023
BIO International Convention
We are excited to share that we will be attending the BIO International Convention in Boston. This leading industry event attracts biotechnology and pharma leaders for one week of intensive(...)
Biotech Pharma
Blog April 17, 2023
Reimbursement of Rare Disease Drugs in Italy: Challenges and Hopes for the Future
When it comes to rare diseases, Italy has done a good job in bringing EMA-approved drugs, including orphan drugs, to the Italian market. But  multiple challenges exist, many of which(...)
Italy Market Access Pharma Rare Disease Real-World Evidence (RWE)
Blog April 17, 2023
Pharmaceutical Market Access in the UK: A Changing Landscape
Start reading this interview with Rachel Fyson to gain insight into the changing landscape of market access in the United Kingdom.
Market Access Pharma UK
Blog April 14, 2023
Lifecycle Optimization: The Path to Commercial Success
Pharmaceutical and biotech companies constantly focus on product innovation. But how can you also increase your effectiveness in order to be as commercially competitive and efficient as possible?
Market Access MedTech Pharma
See all news
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.